Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

31 results about "Sensitivity drugs" patented technology

Neural network drug dosage estimation

Neural networks are constructed (programmed), trained on historical data, and used to predict any of (1) optimal patient dosage of a single drug, (2) optimal patient dosage of one drug in respect of the patient's concurrent usage of another drug, (3a) optimal patient drug dosage in respect of diverse patient characteristics, (3b) sensitivity of recommended patient drug dosage to the patient characteristics, (4a) expected outcome versus patient drug dosage, (4b) sensitivity of the expected outcome to variant drug dosage(s), (5) expected outcome(s) from drug dosage(s) other than the projected optimal dosage. Both human and economic costs of both optimal and sub-optimal drug therapies may be extrapolated from the exercise of various optimized and trained neural networks. Heretofore little recognized sensitivities-such as, for example, patient race in the administration of psychotropic drugs-are made manifest. Individual prescribing physicians employing deviant patterns of drug therapy may be recognized. Although not intended to prescribe drugs, nor even to set prescription drug dosage, the neural networks are very sophisticated and authoritative "helps" to physicians, and to physician reviewers, in answering "what if" questions.
Owner:PREDICTION SCI

Application of ursane pentacyclic triterpenoids in preparing tumor radiotherapy sensitivity drugs

The invention discloses application of ursane pentacyclic triterpenoids in preparing tumor radiotherapy sensitivity drugs. A general molecular formula of the ursane pentacyclic triterpenoids is shownin a formula I. It is found for the first time that the ursane pentacyclic triterpenoids can increase the sensitivity of tumor cells to irradiation by inhibiting the activity of SUMO-specific proteases 1 (SENP1), and the ursane pentacyclic triterpenoids are expected to become new tumor radiotherapy sensitivity drugs. (Please see the description for the formula).
Owner:INST OF RADIATION MEDICINE CHINESE ACADEMY OF MEDICAL SCI

Method for preparing reduction-sensitive medicine nano-agent for diagnoses and treatment through single-walled carbon nanotubes modified through hyaluronic acid and application of method

The invention relates to a method for preparing a reduction-sensitive medicine nano-agent for diagnoses and treatment through single-walled carbon nanotubes modified through hyaluronic acid and application of the method. The method can effectively solve the problems that tumor targeting of the anti-cancer drug adriamycin is poor, toxic and side effects are large, targeting is poor, relaxivity is low and the half-life period is short. According to a transport system, the single-walled carbon nanotubes modified through the hyaluronic acid are connected with the adriamycin through 3,3'-dithio-thiodipropionic acid serving as a joint arm, then gadolinium chloride is adsorbed to the single-walled carbon nanotubes, and the single-walled carbon nanotubes modified through the hyaluronic acid are formed through dispersion of a surface active agent. The reduction-sensitive medicine nano-agent used for diagnoses and treatment has the advantages that biocompatibility and tumor targeting are good, thermal therapy and chemotherapy are combined, and diagnosis and treatment are combined, is an innovation of tumor diagnosis and treatment medicine, and is large in economic and social benefit.
Owner:ZHENGZHOU UNIV

Use of PUMA in tumor chemoradiotherapy sensibilization

An application of external PUMA gene or the cDNA or protein containing PUMA BH3 structure domain in preparing the sensitive medicine for radiotherapy or chemicotherapy of cancer cells is disclosed.
Owner:CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI

Method for synthesizing nicotinyl amino acids and sensitizing effect thereof to tumor radiotherapy

The invention provides a nicotinoyl amino compound with a general formula I or acceptable salts in pharmacy thereof. While the maternal structure of niacinammide is maintained, compounds such as amino monoacid and amino dibasic acid, etc., are introduced into a side chain of the niacinammide; radiotherapy sensitivity experiments on tumors show that the synthesized compounds all have sensitivity effects of different degrees. The invention also provides the series compound with the general formula I or acceptable salts in pharmacy thereof, which can be used as an effective component in application of preparing the radiotherapy sensitivity drugs for curing liver cancer, lung cancer, cervical cancer, breast cancer, lymph cancer and nasopharyngeal carcinoma.
Owner:INST OF RADIATION MEDICINE CHINESE ACADEMY OF MEDICAL SCI

Composite medicine for treating toothache quickly and effectively

InactiveCN101185758AGood effectSafe and reliable medicineAntisepticsDigestive systemDiseasePhenylbutazone
The invention particularly relates to a drug for rapid-acting treatment of toothache. The drug integrates various causes of toothache disease and carries out the compounding of antibiotic anti-inflammatory drug, anti-spirit sensitivity drug, anti-anaerobic infection drug, anti-inflammatory analgesic drug and other various western patent drugs, and the compound drug mainly consists of drug cefalexin or other antibiotic anti-inflammatory drug, tiapride hydrochloride, metronidazole or other anti-anaerobic infection drug, indometacin enteric-coated tablet, phenylbutazone and prednisone hydrochloride sequentially according to the mixing ratio by weight parts. The drug of the invention is rapid in acting for the toothache disease which is formed by various causes, and generally the drug can act in 1 to 1.5 hours after the drug administration, the pain can be stopped after one week of the drug administration, and the effect is significant; the effective rate of the rapid pain stopping is 98 percent and the cure rate is 96.5 percent according to the statistics; the used drugs of the invention are the patent drugs which are proved by the state and the efficacies of the drugs are safe and reliable; the administration is convenient, which is easy to be accepted by patients.
Owner:严晓丽

Application of human miR-148a to preparation of medicine for improving adipose cell insulin sensitivity

The invention belongs to the field of gene engineering, discloses an application of human miR-148a to preparation of medicine for improving adipose cell insulin sensitivity, and provides an application of human miR-148a to preparation of medicine for improving adipose tissue insulin sensitivity and / or promoting glucose uptake of adipose tissue under a state of insulin stimulation in the technical scheme. Researches show that overexpression of the human miR-148a in adipose cells can obviously promote glucose uptake of the adipose cells under the state of insulin stimulation, and the human miR-148a can be used for preparing the medicine for improving adipose tissue insulin sensitivity and / or promoting glucose uptake of the adipose tissue under the state of insulin stimulation as well as used for preparing medicine for preparing diabetes mellitus type 2.
Owner:NANJING MATERNITY & CHILD HEALTH CARE HOSPITAL

Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof

Solid oral dosage forms that include melt granules of a moisture-sensitive therapeutic compound and a hydrophobic melt component. The melt granules better protect the therapeutic compound from hydrolytic degradation. Such solid oral dosage forms also possess immediate-release characteristics rather than that associated with extended-release or controlled-release drug products.
Owner:NOVARTIS AG

Application of peiminine for preparing drug for improving sensitivity of tumor cells to chemotherapy drugs

The invention relates to the technical field of application of peiminine, and discloses application of peiminine for preparing a drug for improving sensitivity of tumor cells to chemotherapy drugs. The invention proposes the application of the peiminine for preparing the drug for improving the sensitivity of esophagus cancer cells, liver cancer cells, breast cancer cells, cervical carcinoma cells and lung cancer cells to chemotherapy drugs for the first time, and combination of the peiminine and the chemotherapy drugs can improve the sensitivity of the tumor cells to the chemotherapy drugs, and can obviously inhibit proliferation of the esophagus cancer cells, liver cancer cells, breast cancer cells, cervical carcinoma cells and lung cancer cells, thereby providing a new means for improving the therapeutic effects on esophagus cancer, liver cancer, breast cancer, cervical carcinoma and lung cancer.
Owner:XINJIANG INST OF MATERIA MEDICA

Production method of 3D printed artificial bone

An embodiment of the invention provides a production method of 3D printed artificial bone and relates to the technical field of medicine. The method comprises the steps as follows: a 3D graph is obtained through 3D CT; a 3D model of a closed bone window is obtained according to the 3D graph; a first sensitive drug is obtained; a second sensitive drug is obtained, and a lactic acid-acetic acid containing copolymer with the weight percentage being 0.1%-20% is dissolved with 1,4-dioxane into a solvent; the first sensitive drug is dissolved in the solvent and a first suspension is prepared; a calcium-containing compound with the weight percentage being 5%-50% is added to the first suspension and a first solid is prepared; the second sensitive drug is dissolved in the solvent and a second suspension is prepared; after the first solid is added to the second suspension, a calcium-containing compound with the weight percentage being 5%-30% is added to serve as a raw material, and a first pastymaterial is prepared; the first pasty material is added to a 3D printer for printing and first artificial bone is formed. The technical problem that drugs cannot be kept at affected parts in the prior art is solved, and the technical effects of drug closing and increase of later can be realized.
Owner:迈海新型材料科技(固安)有限公司

Application of GRP78 gene in drug for improving chemotherapy sensitivity of tumor stem cells

The invention relates to the field of chemotherapy of tumor stem cells, in particular to application of a GRP78 gene in a drug for improving chemotherapy sensitivity of tumor stem cells as well as a screening method adopting the GRP78 gene as an effect target inhibitor. The effect target of the inhibitor is the GRP78 gene, the GRP78 gene is correlated to the drug-resisting characteristics of the tumor stem cells, and the inhibitor inhibits the expression of GRP78 gene in the tumor stem cells, so that the content of a chemotherapy drug in the tumor stem cells is increased, and the chemotherapysensitivity of the tumor stem cells can be improved. By adopting the application of the GRP78 gene, the sensitivity of the tumor stem cells to the chemotherapy drug can be improved, the curative effect of the chemotherapy drug can be improved, the lifetime of a tumor patient can be prolonged, a chemotherapy response rate of the tumor patient can be increased, and a potential and good application prospect in the drug for improving the chemotherapy sensitivity of the tumor stem cells can be realized.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

A kind of high bioavailability rapamycin composition and preparation method

The invention relates to a high bioavailability rapamycin composition and a preparation method. The drug release of the solid drug composition in the gastrointestinal tract has pH sensitivity, and the high dispersibility of the drug in the carrier can significantly increase the rapamycin composition. The absorption of pamycin in the gastrointestinal tract or other properties of the drug can be improved, the bioavailability can be significantly improved, the dosage can be reduced, that is, the amount of raw materials in the preparation can be reduced, and the production cost can be greatly saved. The rapamycin of the present invention The composition can be processed into various oral solid dosage forms, and the preparation process is simple.
Owner:PEKING UNIV

A kind of manufacturing method of 3D printing artificial bone

Embodiments of the invention provide a manufacturing method for 3D-printed artificial bone, belonging to the field of medical technology. The manufacturing method comprises the following steps: acquiring a first sensitive medicine; acquiring a second sensitive medicine; dissolving chitosan with weight percentage of 1 to 90 wt% in double-distilled water to obtain a solvent; dissolving the first sensitive medicine in the solvent and preparing a first suspension; adding a calcium-containing compound with weight percentage of 5 to 50% into the first suspension to prepare a first solid; dissolvingthe second sensitive medicine in the solvent and preparing a second suspension; adding the first solid into the second suspension, and then adding a calcium-containing compound with weight percentageof 0.5 to 30% to prepare a first paste material; and adding the first paste material into a biological 3D printer for printing so as to form the first artificial bone. In a medicine-containing paste material for the artificial bone, the medicine-containing solid is prepared from chitosan and double-distilled water, so a plurality of medicines are released at the same time; and drug effect is improved due to combined usage of the medicines.
Owner:PARTICLE CLOUD BIOTECHNOLOGY (HANGZHOU) CO LTD

Use of PUMA in tumor chemoradiotherapy sensibilization

An application of external PUMA gene or the cDNA or protein containing PUMA BH3 structure domain in preparing the sensitive medicine for radiotherapy or chemicotherapy of cancer cells is disclosed.
Owner:CANCER INST & HOSPITAL CHINESE ACADEMY OF MEDICAL SCI

A dual-sensitive targeting nanoparticle preparation loaded with chemotherapy drugs and its preparation method

The present disclosure provides a dual-sensitive targeting nanoparticle preparation loaded with chemotherapy drugs and a preparation method thereof. The nanoparticle preparation includes an amphiphilic polymer, the amphiphilic polymer includes gelatin, at least one molecule of a chemotherapy drug, each The molecules of the chemotherapeutic drug are chemically bonded to the gelatin through a first chemical group, and the main chain of the first chemical group contains a disulfide bond. Among them, the disulfide bond is redox sensitive and can be broken to release the drug when the concentration of glutathione around the tumor tissue is high. At the same time, gelatin, as the substrate of the MMP-2 enzyme, can be degraded into small particles by the overexpressed MMP-2 enzyme around the tumor tissue, increasing the penetration in the tumor tissue, thereby achieving dual-sensitive drug release.
Owner:SHANDONG UNIV

Application of C10orf116 genes in preparing medicament for improving insulin sensitivity of adipose tissue

The invention belongs to the field of genetic engineering, and discloses the application of C10orf116 genes in preparing a medicament for improving the insulin sensitivity of an adipose tissue. The application of C10orf116 genes in preparing a medicament for improving the insulin sensitivity of an adipose tissue and / or a medicament for promoting the glucose absorption of the adipose tissue disclosed by the invention provides a new technical scheme for preparing a medicament for improving the insulin sensitivity of an adipose tissue and / or a medicament for promoting the glucose absorption of the adipose tissue.
Owner:郭锡熔 +8

Application of nod1/2 in the preparation of drugs for improving the sensitivity of tumor cells to chemotherapeutic drugs

The invention belongs to the field of biological medicine, and particularly relates to an application of NOD1 / 2 in preparing medicament for improving the sensitivity of tumor cells to chemotherapeuticmedicine. The invention finds that the NOD1 and the NOD2 both can improve the chemosensitivity of hepatoma carcinoma cells for the first time. The NOD1 increases the chemosensitivity of the hepatomocarcinoma cells by inhibiting a p-SRC-MAPK signal axis, and the inhibitory effect of the NOD1 on the hepatomo carcinoma cells has a certain synergistic effect with a 5-FM. The NOD2 enhances the chemosensitivity of the hepatomo carcinoma cells by activating a AMPK signal pathway, and the inhibitory effect of the NOD2 on the hepatomo carcinoma cells has the certain synergistic effect with the 5-FM.The application of the NOD1 / 2 gene in improving the chemosensitivity of the hepatoma carcinoma cells obviously improves the chemotherapy result and can reduce side effects caused by the chemotherapy.
Owner:SHANDONG UNIV

Method for producing 3D printed artificial bone

An embodiment of the invention provides a method for producing a 3D printed artificial bone. The method comprises the following steps: obtaining a 3D graphic through 3D CT; obtaining a modeling technology according to the 3D graphic and obtaining a 3D model of a closed bone window; obtaining a first sensitive drug and a second sensitive drug; preparing a first paste material from the first sensitive drug; adding the first paste material to a biological 3D printer for printing to form an inner layer; preparing a second paste material from the second sensitive drug; adding the second paste material to the biological 3D printer for printing on the basis of inner layer to form the artificial bone. The technical problems that requirements of different types of orthopedic surgery cannot be met and drugs cannot remain at parts requiring the drugs to play a role due to absence of a bone window closing system in the prior art are solved, and the technical effects that the artificial bone is matched with a bone window structure by means of 3D printing, drug blockage is facilitated and bone mass can be increased in late stage are realized.
Owner:迈海新型材料科技(固安)有限公司

System for identifying cancer stem cells and detecting drug sensitivity and detection method thereof

The invention provides a system for identifying cancer stem cells and detecting drug sensitivity and a detection method thereof. The system comprises an incubator, a tissue culture unit, a reagent loading unit, a liquid transfer unit, a laser unit, a microscope unit, a control unit and a power supply unit, wherein the incubator comprises a box door and a box body; the functional units are arrangedin the box body; a partition board is arranged in the middle of the box body; the tissue culture unit is arranged in a front box body, and comprises a tissue culture platform composed of a pluralityof tissue culture tanks; tumor tissue sections to be measured are arranged in the tissue culture tanks in sequence; and the reagent loading unit is used for loading liquid reagents such as cell culture mediums, dye solutions and washing liquids, and is located in a back box body. The system can realize the efficient recognition of cancer stem cells in tissue slices of cancer stem cells, and quickly obtain sensitive drugs that can inhibit and eliminate the cancer stem cells.
Owner:NANCHANG DEMANDUO TECH CO LTD

Micro-extraction stirring bar device for solid adsorption material and use method thereof

The invention relates to a micro-extraction stirring bar device for a solid adsorption material and a use method thereof. The device comprises an extraction bottle, a magnetic stirrer, a micro-extraction stirring bar, and a base. A magnet stirrer is arranged in the base. The base is snapped on the micro-extraction stirring bar. The micro-extraction stirring bar is a hollow glass tube, two ends ofthe hollow glass tube are sealed by porous films, and a solid adsorption material is filled in the porous films and the hollow glass. When the device is used, the micro-extraction stirring bar is snapped on the base. A conventional solid phase micro-extraction stirring bar has the disadvantages that magnets are filled in the hollow glass, a solid adsorption material is wrapped on the glass, duringthe stirring process, the adsorption material is worn by the rotation of the solid phase micro-extraction stirring bar and the bottom of the container, and the provided device solves the problems mentioned above. The base is arranged in the extraction bottle, the extraction bottle is placed on a magnetic stirring device, the magnet stirrer rotates in the magnetic stirring device to drive the micro-extraction stirring bar so as to stir the solution, and the extraction is carried out by the solid adsorption material in the micro-extraction stirring bar.
Owner:西安点云生物科技有限公司

Manufacturing method for 3D-printed artificial bone

Embodiments of the invention provide a manufacturing method for 3D-printed artificial bone, belonging to the field of medical technology. The manufacturing method comprises the following steps: acquiring a first sensitive medicine; acquiring a second sensitive medicine; dissolving chitosan with weight percentage of 1 to 90 wt% in double-distilled water to obtain a solvent; dissolving the first sensitive medicine in the solvent and preparing a first suspension; adding a calcium-containing compound with weight percentage of 5 to 50% into the first suspension to prepare a first solid; dissolvingthe second sensitive medicine in the solvent and preparing a second suspension; adding the first solid into the second suspension, and then adding a calcium-containing compound with weight percentageof 0.5 to 30% to prepare a first paste material; and adding the first paste material into a biological 3D printer for printing so as to form the first artificial bone. In a medicine-containing paste material for the artificial bone, the medicine-containing solid is prepared from chitosan and double-distilled water, so a plurality of medicines are released at the same time; and drug effect is improved due to combined usage of the medicines.
Owner:PARTICLE CLOUD BIOTECHNOLOGY (HANGZHOU) CO LTD

pH-sensitive carrier and production method thereof, pH-sensitive drug containing the same, pH-sensitive drug composition, and culture method using the same

The present invention provides a pH-sensitive carrier that can serve as a carrier for physiologically active substances and exhibit a membrane-destroying function-promoting effect in response to a weakly acidic environment, a manufacturing method thereof, and a pH-sensitive drug and a pH-sensitive drug combination containing the carrier. Objects, and cultivation methods using the same. The pH-sensitive carrier exhibits a membrane destruction function promoting effect and includes: selected from the group consisting of deoxycholic acid, cholic acid, ursodeoxycholic acid, chenodeoxycholic acid, hyodeoxycholic acid, higher bile acids, glycinodeoxycholic acid, and licorice. At least one pH-sensitive compound among acid, glycyrrhetinic acid and their salts; and phosphatidylcholine with 10 to 12 carbon atoms and polyoxyethylene sorbitan monofat with 12 to 18 carbon atoms. Acid esters, sorbitan fatty acid esters with 16 to 18 carbon atoms, glyceryl monooleate, glyceryl dilaurate, glyceryl distearate, glyceryl dioleate, polyoxyethylene castor oil and At least one amphiphilic substance in α-tocopherol.
Owner:TERUMO KK

Preparation method of drying type preparation for 3D printing artificial bone manufacturing

The invention provides a preparation method of a drying type preparation for 3D printing artificial bone manufacturing, and relates to the technical field of medicine. Copolymer with 0.1 to 20 wt% ofethyl lactate is dissolved by 1,4-dioxane to form a solvent; a first sensitive drug is dissolved in the solvent to form first turbid liquid; a first solid is prepared; then a second sensitive drug isdissolved to manufacture second turbid liquid; the first solid is added into second turbid liquid to prepare a first paste like material; the first paste like material is frozen and dried to form a granular first preparation intermediate product; and the first preparation intermediate product is split, filled, and sealed to form the drying type preparation. The drying type preparation solves the problems that in the prior art, in clinic, the sustained release drugs cannot be co-used with other drugs and are difficult to store. The provided drying type preparation can simultaneously carry different kinds of drugs, can be directly used, is convenient and hygiene, and is easy to store, and the using amount is controllable.
Owner:河北点云生物科技有限公司

Method and application of hyaluronic acid-modified single-walled carbon nanotubes for preparation of reduction-sensitive drug nano-agents for diagnosis and treatment

The invention relates to a method and application of hyaluronic acid-modified single-walled carbon nanotubes for preparing reduction-sensitive drug nano-agents for diagnosis and treatment, which can effectively solve the problems of poor tumor targeting, large toxic and side effects, poor targeting, and relaxation of the anticancer drug doxorubicin. In order to solve the problems of low efficiency and short half-life, the delivery system consists of hyaluronic acid-modified single-walled carbon nanotubes connected to doxorubicin through 3,3'-dithiodipropionic acid as a connecting arm, and then trichloride Gadolinium is adsorbed on the single-walled carbon nanotubes, and then dispersed with a surfactant to form single-walled carbon nanotubes modified with hyaluronic acid, which is used as a nano-preparation of reduction-sensitive drugs for diagnosis and treatment. The present invention has good biocompatibility , Good tumor targeting, combination of hyperthermia and chemotherapy, diagnosis and treatment as a whole, is an innovation in the diagnosis and treatment of tumor drugs, with huge economic and social benefits.
Owner:ZHENGZHOU UNIV

Application of C10orf116 genes in preparing medicament for improving insulin sensitivity of adipose tissue

The invention belongs to the field of genetic engineering, and discloses the application of C10orf116 genes in preparing a medicament for improving the insulin sensitivity of an adipose tissue. The application of C10orf116 genes in preparing a medicament for improving the insulin sensitivity of an adipose tissue and / or a medicament for promoting the glucose absorption of the adipose tissue disclosed by the invention provides a new technical scheme for preparing a medicament for improving the insulin sensitivity of an adipose tissue and / or a medicament for promoting the glucose absorption of the adipose tissue.
Owner:郭锡熔 +8

Method for producing injection type preparation for 3D printed artificial bone

An embodiment of the invention provides a method for producing an injection type preparation for 3D printed artificial bone and relates to the technical field of medicine. The method comprises the steps as follows: a lactic acid-acetic acid containing copolymer with the weight percentage being 0.1%-20% is dissolved with 1,4-dioxane into a solvent; a first sensitive drug is dissolved in the solventand a first suspension is prepared; a first solid is prepared; a second sensitive drug is dissolved and a second suspension is prepared; a first pasty material is prepared after the first solid is added; the first pasty material is subjected to freeze drying to form a first preparation intermediate; then, the first preparation intermediate is mixed with a suspension of hydroxyapatite, the obtained mixture is placed in a syringe and the injection type preparation is formed. The problems that clinically applied slow release drugs are of the single kind, combined use of multiple drugs cannot berealized and the drugs are not easy to store in the prior art are solved, and the technical effects that multiple different drugs can be carried simultaneously and taken when used, the dosage is controllable and the injection type preparation is convenient and sanitary are realized.
Owner:河北点云生物科技有限公司

Manufacturing method of 3D printed artificial bone

ActiveCN107875445AMeeting Orthopedic Surgery NeedsLong release timeTissue regenerationProsthesisRelease timeArtificial bone
The invention provides a manufacturing method of a 3D printed artificial bone, and relates to the technical field of medicine. The manufacturing method comprises the following steps: obtaining a firstsensitive drug; obtaining a second sensitive drug, wherein the sensitivity of the first sensitive drug is lower than that of the second sensitive drug; dissolving 0.1 to 20 wt% of copolymer containing ethyl acetate into 1,4-dioxane to form a solvent; dissolving the first sensitive drug in the solvent to form a first turbid liquid; adding 5 to 50 wt% of calcium containing compounds into the firstturbid liquid to prepare a first solid; dissolving the second sensitive drug in the solvent to form a second turbid liquid; adding the first solid into the second turbid liquid, then adding 0.5 to 30wt% of calcium containing compounds to prepare a first paste like material; adding the first paste like material into a biological 3D printing machine, and carrying out printing to form a first artificial bone. The technical effects of step-by-step drug administration and prolonged sustained release time are realized.
Owner:PARTICLE CLOUD BIOTECHNOLOGY (HANGZHOU) CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products